For years, hormone replacement therapies prescribed to treat menopause symptoms have come with warning labels on risks ...

The Food and Drug Administration announced that hormone therapies for menopause will no longer need a black box warning about ...

The agency says clinical trials show no association with increased breast cancer risk.

The U.S. Food and Drug Administration said on Monday it would remove the strictest "black box" warnings from hormone ...

Scan 60–90 days of card/bank statements and make a “hit list” of anything recurring, vague, or annual — you can’t cancel what ...

Suspension systems have come a long way, with a barrage of smarter and active systems once unheard of not that long ago.

The U.S. Food and Drug Administration said Monday it would erase its sweeping warnings about hormone replacement therapy for menopausal women given its potential for overall benefit to women’s ...

The decision, issued without the input of an official advisory committee, revises long-held labeling on the drugs cautioning ...

From oral therapy, to rings, creams and transdermal patches, there are lots of estrogen therapy options for women in menopause. Who is a good candidate for hormone therapy and what are the nonhormonal ...

NPR's Juana Summers talks to FDA Commissioner Martin Makary about the administration's decision to remove the black box ...